Medicare Enrolled
Dr. Maryann Park, M.D
Pulmonary Disease · Middletown, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Park from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Park?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Park
Dr. Maryann Park is a pulmonary disease specialist in Middletown, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Park performed 3,315 Medicare services across 2,120 unique beneficiaries.
Between the years covered by Open Payments, Dr. Park received a total of $43,671 from 42 pharmaceutical and/or device companies across 685 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Park is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 10% volume in NY
$43,671 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,315
Medicare services
Top 10% in NY for pulmonary disease
2,120
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~166 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,153 | $105 | $141 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
278 | $12 | $16 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
175 | $66 | $87 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
144 | $46 | $65 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
144 | $37 | $50 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
144 | $47 | $64 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
142 | $34 | $44 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
134 | $73 | $98 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
132 | $148 | $191 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
123 | $16 | $16 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
117 | $133 | $189 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
117 | $73 | $99 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
58 | $20 | $27 |
| COVID-19 immunoassay detection test A laboratory test that uses an immunoassay method to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) through direct visual observation. |
54 | $41 | $116 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
44 | $29 | $30 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
41 | $7 | $7 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
41 | $101 | $135 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
38 | $519 | $721 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
34 | $71 | $80 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
32 | $525 | $799 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
32 | $66 | $99 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
27 | $16 | $22 |
| COVID-19 nucleic acid test, high throughput A laboratory test that detects the genetic material of the SARS-CoV-2 virus using an amplified probe technique. This method utilizes high-throughput technologies to process samples. |
26 | $74 | $75 |
| COVID-19 nucleic acid test, high throughput A laboratory test that detects the genetic material of the SARS-CoV-2 virus using amplified probe techniques. This method utilizes high-throughput technologies to process samples efficiently. |
26 | $24 | $25 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
19 | $281 | $287 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
15 | $8 | $8 |
| Low dose CT scan of chest for lung cancer screening A specialized CT scan of the chest using a lower radiation dose to screen for lung cancer. |
13 | $101 | $158 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
12 | $92 | $149 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$43,671
Total received (2018-2024)
Avg $6,239/year across 7 years
Top 8% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
685
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$31,536 (72.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,135 (27.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,632
2023
$2,317
2022
$10,489
2021
$5,992
2020
$2,901
2019
$10,272
2018
$9,068
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$736
GENZYME CORPORATION
$317
HARMONY BIOSCIENCES LLC
$307
Amgen Inc.
$276
Inspire Medical Systems, Inc.
$174
Regeneron Healthcare Solutions, Inc.
$165
Boehringer Ingelheim Pharmaceuticals, Inc.
$146
Mallinckrodt Hospital Products Inc.
$123
Avadel CNS Pharmaceuticals, LLC
$75
GlaxoSmithKline, LLC.
$52
ANI Pharmaceuticals, Inc.
$43
PFIZER INC.
$38
Actelion Pharmaceuticals US, Inc.
$35
Electromed, Inc.
$31
Novartis Pharmaceuticals Corporation
$26
Takeda Pharmaceuticals U.S.A., Inc.
$23
Mylan Specialty L.P.
$20
Tactile Systems Technology Inc
$18
Axsome Therapeutics, Inc.
$14
United Therapeutics Corporation
$13
Top 3 companies account for 51.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$18,979
Boehringer Ingelheim Pharmaceuticals, Inc.
$15,267
GlaxoSmithKline, LLC.
$1,361
GENZYME CORPORATION
$1,249
Regeneron Healthcare Solutions, Inc.
$933
Actelion Pharmaceuticals US, Inc.
$516
Novartis Pharmaceuticals Corporation
$465
JAZZ PHARMACEUTICALS INC.
$366
Amgen Inc.
$352
Grifols USA, LLC
$344
Genentech USA, Inc.
$320
HARMONY BIOSCIENCES LLC
$307
Mylan Specialty L.P.
$306
Jazz Pharmaceuticals Inc.
$302
Harmony Biosciences LLC
$273
Sunovion Pharmaceuticals Inc.
$238
Mallinckrodt Hospital Products Inc.
$232
Takeda Pharmaceuticals U.S.A., Inc.
$217
Circassia Pharmaceuticals Inc
$176
Inspire Medical Systems, Inc.
$174
PFIZER INC.
$165
Axsome Therapeutics, Inc.
$127
Electromed, Inc.
$119
Avadel CNS Pharmaceuticals, LLC
$108
Shire North American Group Inc
$93
Bayer Healthcare Pharmaceuticals Inc.
$91
Mallinckrodt Enterprises LLC
$88
Baxter Healthcare
$77
ANI Pharmaceuticals, Inc.
$61
Mallinckrodt LLC
$53
Exeltis, USA Inc.
$52
Teva Pharmaceuticals USA, Inc.
$40
Bayer HealthCare Pharmaceuticals Inc.
$38
Paratek Pharmaceuticals, Inc.
$33
Advanced Respiratory, Inc
$32
E.R. Squibb & Sons, L.L.C.
$24
Tactile Systems Technology Inc
$18
Biohaven Pharmaceuticals, Inc.
$16
Philips Electronics North America Corporation
$16
Insmed, Inc.
$14
United Therapeutics Corporation
$13
Novo Nordisk Inc
$12
Top 3 companies account for 81.5% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Adempas · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CINQAIR · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIQUIS · Esbriet · FASENRA · Flexitouch Plus · GLASSIA · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INSPIRE · LONHALA MAGNAIR · LUMRYZ · Life 2000 Ventilation System · NIOX VERO · NUCALA · NURTEC ODT · NUZYRA · OFEV · OFIRMEV · OPSUMIT · OPSUMIT MACITENTAN · PREVNAR 13 · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C Liquid · SHINGRIX · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Saxenda · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · UPTRAVI · UTIBRON · UTIBRON NEOHALER · Utibron · WAKIX · Wakix · XOLAIR · XYREM · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (72%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for pulmonary disease in NY.
Geographic Context
Pulmonary diseases within 10 mi
14
Per 100K population
3.5
County median income
$96,497
Nearest hospital
GARNET HEALTH MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Park is a clinical cardiology specialist, with above-average Medicare volume (top 10% in NY), with speaking/promotional industry engagement in the top 8% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Park experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Park performed 1,153 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Park receive payments from pharmaceutical companies?
Yes. Dr. Park received a total of $43,671 from 42 companies across 685 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Park's costs compare to other pulmonary diseases in Middletown?
Dr. Park's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Park) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Middletown
Browse pulmonary diseases in Middletown ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NY
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NY
Which NY pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology